- Details
- Tamer Aboushwareb, Vice President of Medical Affairs, Pacific Edge, Ltd provides an overview of the Cxbladder Monitor urine-based cancer surveillance test and is joined by Neal Shore and Josh Meeks for a discussion on the clinical implications of the use of this test. Several supportive publications are highlighted and Drs Shore, Meeks, and Aboushwareb discuss the Cxbladder Monitor algorithm, its...
|
- Details
- Tamer Aboushwareb, Vice President of Medical Affairs, Pacific Edge, Ltd provides an overview of the Cxbladder Detect urine-based cancer diagnostic test and is joined by Neal Shore and Josh Meeks for a discussion on the clinical implications of the use of this test which is designed for high-risk patients who present with hematuria. Cxbladder is a suite of non-invasive, urine-based laboratory tests...
|
- Details
- In this discussion, Max Kates and Trinity Bivalacqua join Ashish Kamat in reviewing Blue Light Cystoscopy (BLC®) with Cysview®, specifically highlighting the New Blue Light Powered by Saphira® providing next-level visualization being used with Photocure’s Cysview® product in BLC® procedures for the detection of non‐muscle invasive bladder cancer (NMIBC). The new Blue Light system was approved on F...
|
- Details
- In this discussion, Ashish Kamat moderates a debate between Sia Daneshmand and Trinity Bivalacqua comparing the benefits of enhanced cystoscopy with blue light cystoscopy in TURBT to the benefits of perioperative chemotherapy following TURBT. Dr. Daneshmand discusses the role of blue light cystoscopy (BLC ®) in TURBT that there is an improvement in detecting tumors and their respective margins dur...
|
- Details
- Kristen Scarpato, Svetlana Avulova, and Anne Schuckman join Sima Porten in this conversation on the realities of diagnosis and treatment of bladder cancer in women. They start by evaluating a patient case to highlight some women who present with bladder cancer and discuss what's most important when we talk about caring for these patients and how to improve care. Biographies: Sima P. Porten, MD, MP...
|
- Details
- Alicia Morgans is joined by Jeannie Hoffman-Censits and Elizabeth Guancial to discuss the challenges women face navigating a bladder cancer diagnosis. In 2022, the American Cancer Society estimates more than 81,000 will be diagnosed with bladder cancer in the United States. Of those, 61,700 will be men, and 19,480 will be women. Drs. Morgans, Hoffman-Censits, and Guancial discuss the importance of...
|
- Details
- For this Journal Club, Christopher Wallis, MD, and Zach Klasseen, MD discuss a recently published meta-analysis on treatment options for patients with non-muscle invasive bladder cancer unresponsive or refractory to BCG therapy. They provide context for this review and discuss the clinical relevance of managing the risk of recurrence in NMIBC. Biographies: Zachary Klaassen, MD, MSc, Urologic Oncol...
|
- Details
- Siamak (Sia) Daneshmand joins Ashish Kamat in a discussion on the role of blue-light cystoscopy (BLC) in detecting invasive bladder tumors. Providing background on the beneficial use of BLC in carcinoma in situ (CIS), Dr. Daneshmand highlights the evidence on the potential of finding additional TA tumors with the use of BLC. He showcases data from a BJUI multi-institutional registry publication on...
|
- Details
- Ashish Kamat is joined by Patrick Lewicki to discuss the recent publication on the underutilization of Blue Light Cystoscopy (BLC) in the United States. Studying the use of BLC in the Premier Healthcare Database, the findings demonstrate a low level of BLC use despite guideline recommendations and evidence demonstrating the benefit for its use in the management of non-muscle invasive bladder cance...
|
- Details
- In this UroToday journal club, Christopher Wallis and Zachary Klaassen highlight a European Urology Focus publication entitled Underutilization of Blue Light Cystoscopy for Bladder Cancer in the United States. Blue light cystoscopy (BLC) for the management of nonmuscle invasive bladder cancer (NMIBC) is an evidence- and guideline-supported intervention that has been shown to increase cancer detect...
|
